The Inhibin B Response to the Testicular Toxicant 1, 3 Dinitrobenzene in Male Rats
Article first published online: 24 JAN 2013
© 2013 Wiley Periodicals, Inc.
Birth Defects Research Part B: Developmental and Reproductive Toxicology
Special Issue: Part B: Developmental and Reproductive Toxicology
Volume 98, Issue 1, pages 29–34, February 2013
How to Cite
Sonee, M., Bogdan, N., Hall, L., Bryant, S. and Vinken, P. (2013), The Inhibin B Response to the Testicular Toxicant 1, 3 Dinitrobenzene in Male Rats. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 98: 29–34. doi: 10.1002/bdrb.21038
- Issue published online: 5 FEB 2013
- Article first published online: 24 JAN 2013
- Manuscript Accepted: 12 DEC 2012
- Manuscript Received: 7 DEC 2012
- Inhibin B;
- testis histopathology;
- testicular toxicity biomarker;
- Sertoli cell toxicant;
- follicle stimulating hormone
This study was conducted as part of an ILSI-HESI International Life Sciences Institute-Health & Environmental Sciences Institute consortium effort to assess the utility of circulating Inhibin B as an early biomarker of Sertoli cell-specific testicular toxicity in rats. 1, 3-Dinitrobenzene (1,3-DNB) was selected as a testicular toxicant in this study as it is known to target Sertoli cells.
1,3-DNB (2 and 6 mg/kg/day) or control (corn oil) was administered orally to male rats for two or five consecutive days. Blood was collected from rats treated for 2 days on days 1 and 2 and from rats treated for 5 days on days 1, 3, and 5. The resulting serum was evaluated for Inhibin B and follicle stimulating hormone. At the end of the treatment periods, the testes were removed, weighed, and examined histopathologically.
Daily administration of 1,3-DNB resulted in decreased testis weight only on day 5 and only at the high dose (6 mg/kg/day). There was a time-dependent increase in incidence and severity of testicular findings characterized by degeneration of the germinal epithelium with loss of pachytene spermatocytes and vacuolization of the Sertoli cells in the seminiferous tubules at the high dose. Inhibin B levels in 1,3-DNB-treated animals were decreased with treatment only on day 5 at the high dose; there were no associated changes in follicle stimulating hormone.
Changes in serum Inhibin B levels were detected only in association with moderate or severe testicular toxicity as evidenced by histopathology and is therefore considered to be of limited value as a biomarker for Sertoli cell toxicity.